NCDC reports 190 deaths from Lassa fever in 2026, with rising fatality rate.
The Nigeria Centre for Disease Control and Prevention (NCDC) don report say 190 people don die from Lassa fever so far for 2026. According to the latest Lassa Fever Situation Report covering 20 to 26 April, the case fatality rate (CFR) don rise to 25.2 percent, higher than 19.1 percent wey dem record for same period last year.
Published: May 12, 2026.
https://killbait.com/en/ncdc-reports-190-deaths-from-lassa-fever-in-2026-with-rising-fatality-rate/
WHO: Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern.
Determination of a public health emergency of international concern, including a pandemic emergency of the International Health Regulations (2005) (IHR), the Director-General of the World Health Organization (WHO), after having consulted the States Parties where the event is known to be currently occurring, is hereby determining that the Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda constitutes a public health emergency of international concern (PHEIC), but does not meet the criteria of pandemic emergency, as defined in the IHR.
Published: May 17, 2026.
Venezuela reports a rise in cases of malaria in 2026 when compared to the same period in 2025 (in Spanish).
The Venezuelan Ministry of Popular Power for Health (MPPS) reported that from epidemiological week (EW) 1 through EW16 of 2026, a total of 33,955 new and imported malaria cases were recorded, representing a 5.9% increase compared with the same period of the previous year (31,568 cases).
Published: May 19, 2026.
The Ebola Outbreak and the Need for Stronger Global Health Governance.
On 17 May 2026, the World Health Organization (WHO) declared the Ebol outbreak in the Democratic Republic of the Congo (DRC) and Uganda a public health emergency of international concern (PHEIC), noting that while the overall global risk remains low, national and regional risks are elevated due to ongoing transmission, population movement, weak health infrastructure, and the outbreak’s emergence in conflict-affected areas. Although Ebola virus disease (EVD) outbreaks occurred periodically over the past several decades, the current Ebola outbreak in the DRC and Uganda is exposing persistent vulnerabilities within emergency financing, emergency preparedness and coordination at national, regional and global health security systems. It is transpiring in a global context defined by constrained humanitarian financing, geopolitical fragmentation, conflict, and growing pressure on already overstretched health systems.
Published: June 4, 2026.
Graham F. Daily briefing: What it will take to stop the spiralling Ebola outbreak.
Nature. 2026 Jun 1. doi: 10.1038/d41586-026-01782-4.
Published: June 1, 2026.
https://www.nature.com/articles/d41586-026-01782-4
MTBVACN3 advances phase 3 tuberculosis vaccine trial and strengthens African research capacity.
The MTBVACN3 project is advancing the phase 3 clinical development of MTBVAC, a novel tuberculosis (TB) vaccine candidate for newborns in sub-Saharan Africa. The project aims to position MTBVAC as a potential replacement for BCG, which provides only partial protection against pulmonary TB.
Published: June 2026.
Inside – and outside – Namibia’s fight to stop polio before it strikes.
The threat of polio is back, and as the government races to protect the vulnerable, some are more at risk than others.
Published: May 21, 2026.
https://www.gavi.org/vaccineswork/inside-and-outside-namibias-fight-stop-polio-it-strikes
Experimental mRNA vaccine shows promise against multiple Ebola strains.
Scientists from China have developed a new broad-spectrum mRNA vaccine that could provide long-term protection against the most lethal family of Ebola viruses, including the Bundibugyo strain behind the current outbreak in the Democratic Republic of Congo and Uganda.
Published: May 25, 2026.
https://medicalxpress.com/news/2026-05-experimental-mrna-vaccine-multiple-ebola.html
Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push.
Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to $3.8 billion in combined value, signaling its push into infectious disease prevention. The U.S. drugmaker said it had agreed to acquire Curevo, LimmaTech Biologics and Vaccine Company.
Pubished: May 26, 2026.
Statement on vaccine efforts relating to the Bundibugyo Ebolavirus outbreak in the DRC.
In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with Oxford’s own Clinical BioManufacturing Facility and the Serum Institute of India Pvt. Ltd. (SIIPL), to rapidly produce and scale doses of our ChAdOx-based monovalent Bundibugyo Ebolavirus candidate vaccine, ChAdOx1 BDBV.
Published: May 22, 2026.
In Mali, one year in, hybrid malaria vaccine programme shows early results.
Health workers say they are seeing encouraging signs of the vaccine’s impact, even as the programme’s steepest challenge comes into focus: bringing families back for every last dose.
Published: May 20, 2026.
WHO: Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus.
In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic of the Congo, with cases also reported in Uganda, WHO convened several of its expert and advisory groups. These groups assessed potential vaccines and therapeutics for both prevention and treatment of Bundibugyo virus disease (BVD). The WHO advisory groups recommended that all the products identified and considered be used exclusively within clinical trials to generate robust data and ensure safe, ethical, and effective research.
Published: May 28, 2026.
No more needles? Six technologies that could transform how we get vaccinated.
From vaccine patches to sprays, research is accelerating on a number of new ways of delivering protection against the world’s deadliest diseases.
Published: May 26, 2026.
As the largest World Cup ever kicks off, health officials are focused on more than Ebola.
The largest World Cup ever is putting public health systems on alert, though experts say the risk of Ebola remains low because it is not as transmissible as other diseases. (US)Officials and experts are more concerned about highly contagious diseases like measles and respiratory viruses, which can spread quickly through large, fast-moving crowds.
Published: June 5, 2026.
https://www.cnbc.com/amp/2026/06/04/world-cup-2026-health-officials-focused-on-ebola-measles.html
Mass Sloth Deaths in Florida Show Why the Wildlife Trade Is a Pandemic Risk.
When pathologists cut open dead sloths from a planned Florida tourist attraction, they found a plethora of pathogens. Parasites, bacteria and viruses were all lurking in animals weakened by grueling international transport and stressful conditions at the warehouse that received them, according to necropsy records and a state inspection report obtained by Inside Climate News through an open records request. The sloths had distended stomachs, diarrhea matted into fur and lungs congested with pneumonia.
Published: June 7, 2026.
https://www.sej.org/headlines/mass-sloth-deaths-florida-show-why-wildlife-trade-pandemic-risk
World Cup creates perfect conditions for infectious diseases to spread – here are the biggest threats health experts are watching for.
Ebola is indeed a threat, however, COVID-19, measles, and influenza by far much more important.
Published: June 7, 2026.
Health experts to screen US wastewater for disease outbreaks during World Cup.
Epidemiologists will be busy this summer shifting through sewage and social media with the goal of keeping soccer fans and the public safe from severe illness during the World Cup, one of the largest and most globally diverse mass gatherings ever anticipated. A public health squad based in Washington, D.C., plans to monitor wastewater and internet chatter to detect and track infectious diseases should they emerge in any of the U.S. or Canadian cities hosting World Cup players, their matches, and millions of spectators, organizers said.
Published: June 8, 2026.
A strong El Niño is coming: could it lead to more disease outbreaks?
Climate experts warn that we should expect “hotter than normal” temperatures worldwide from June to August this year. Infectious disease specialists say we need to start preparing now.
Published: June 4, 2026.
https://www.gavi.org/vaccineswork/strong-el-nino-coming-could-it-lead-more-disease-outbreaks
Cholera Outbreak: 74 dead, over 7,800 cases strain Borno (Nigeria) facilities.
Médecins Sans Frontières (MSF), also known as Doctors Without Borders, said the outbreak had spread across 14 local government areas and 50 wards, citing figures from the Borno State Ministry of Health.
Published: June 10, 2026.
CEPI awards Public Health Vaccines US$1.9m to accelerate Bundibugyo ebolavirus vaccine.
CEPI has partnered with Public Health Vaccines, LLC. (PHV) to rapidly advance early-stage development of a vaccine candidate against the Bundibugyo ebolavirus in response to the ongoing epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda that has been declared both a continental and global health emergency. CEPI is providing $1.9 million funding to long-standing partner PHV to quickly generate starting vaccine research material, known as Master Viral Seed (MVS) stock*, needed to advance the company’s investigational Bundibugyo virus vaccine into clinical testing.
Published: June 9, 2026.
One World Against Dengue. June 15 is World Dengue Day.
As dengue expands into both longaffected regions and entirely new geographies, the need for coordinated, forwardlooking action has never been greater. A global threat needs a global day: on June 15, World Dengue Day aligns the world’s awareness, inspiring every day to act as One World Against Dengue.
Published: June 2026.
AI-designed universal coronavirus DNA vaccine advances pandemic preparedness with successful first human trial.
A novel AI-designed universal coronavirus DNA vaccine has successfully completed its first human trial, demonstrating a favorable safety profile and broad immune responses. Developed by researchers at the University of Cambridge and DIOSynVax, the vaccine is designed to protect not only against SARS-CoV-2 and SARS, but also against related bat coronaviruses with pandemic potential. Unlike conventional vaccines that target a single virus, artificial intelligence was used to create a synthetic “super-antigen” capable of inducing immunity across the entire Sarbecovirus family. Delivered as a needle-free DNA vaccine using microfluidic jet technology, the candidate generated immune responses against multiple coronaviruses in 39 healthy volunteers without significant adverse effects. While larger Phase 2 studies are still needed, this innovative DNA vaccine platform represents a potentially transformative step toward pandemic preparedness by providing broad protection against future coronavirus threats before they emerge.
Published: June 11, 2026.
One Health in a Fractured World: Why Global Health Governance Must Adapt to Geopolitical Fragmentation.
The COVID-19 pandemic exposed weaknesses in global health systems and underscored how interconnected drivers such as changes in land usage, urbanization, and climate amplify zoonotic disease threats. One Health, an integrated approach linking human, animal, and ecosystem health, has gained institutional traction via global governance approaches, yet faces persistent structural challenges, including siloed mandates, funding misalignment, and limited enforcement.
Published: June 5, 2026.
Nachega JB, Mbala-Kingebeni P, Mulangu S, Ndembi N, Preiser W, Skinner D, Sam-Agudu NA, Ntoumi F, Tegally H, Baxter C, Oliveira T, Bosa HK, Kaleebu P, Kallay O, Uthman OA, Mills EJ, Rosenthal PJ, Zumla A, Muyembe-Tamfum JJ. Ebola outbreak caused by Bundibugyo virus: challenges and priorities for epidemic preparedness and response. Lancet. 2026 Jun 9:S0140-6736(26)01141-4.
Editorial comment: As of June 3, 2026, the ongoing Bundibugyo ebolavirus (BDBV) outbreak had resulted in 344 laboratory-confirmed cases and 60 deaths in the Democratic Republic of the Congo, and 15 confirmed cases with one death in Uganda, highlighting the continuing threat posed by emerging ebolaviruses. The absence of a licensed BDBV-specific vaccine or therapy, coupled with limited access to rapid and reliable diagnostics, underscores persistent gaps in outbreak preparedness and response. Beyond its immediate health impact, the outbreak exposes weaknesses in surveillance systems, laboratory capacity, healthcare infrastructure, and outbreak response capabilities that can facilitate sustained transmission and cross-border spread. These events reinforce the urgent need for broadly protective Ebola vaccines, improved diagnostics, effective therapeutics, and stronger global preparedness systems to prevent future outbreaks from escalating into larger regional or international public health emergencies.
doi: 10.1016/S0140-6736(26)01141-4.
The World’s Game, the World’s Pathogens: Infection Prevention at the FIFA World Cup 2026.
The 2026 edition (running June 11 through July 19 across the US, Mexico, and Canada) is historic in scale: 48 nations, 104 matches, 39 days, and 11 US host cities stretching from Boston to Los Angeles and Seattle to Miami. It is anticipated that between 3 and 5 million domestic and international visitors will descend on these cities, some arriving from countries with meaningfully different infectious disease landscapes than the cities hosting them. For infection preventionists (IPs), hospital epidemiologists, and public health practitioners working in or near any of these host cities, this is not a background event. This is a clinical and operational reality that, if we’re being honest, is probably already giving you a bit of heartburn.
Published: June 10, 2026.
